NCT00125593View on ClinicalTrials.gov

Study of Heart and Renal Protection

PHASE4CompletedINTERVENTIONAL
Enrollment

9,438

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Kidney Disease, Chronic
Interventions
DRUG

Simvastatin 20 mg

Once daily

DRUG

Ezetimibe 10mg

Once daily

DRUG

Placebo

Once daily

Trial Locations (1)

OX3 7LF

Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford, Oxford

Sponsors
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Schering-Plough

INDUSTRY

collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

British Heart Foundation

OTHER

collaborator

Medical Research Council

OTHER_GOV

lead

University of Oxford

OTHER